Maruho, Toray Industries, Inc. To Collaborate In Developing And Marketing Candidate Compound For Atopic Dermatitis Drug
10/19/2005 5:13:11 PM
Tokyo (JCNN) - Maruho and Toray (TSE: 3402) jointly announced that they have concluded an agreement for TRK-820, a drug candidate for treating the itching of atopic dermatitis.
Under the terms of the agreement, set out on March 31, the two companies will jointly conduct R&D for TRK-820. Maruho will be in charge of sales.
comments powered by